ESMED Congress 2021

Hilton Vienna Danube Waterfront Hotel

Feedback from ESMED Congress 2021

The ESMED General Assembly (2022) allowed me to present my work on new optimization methods in drug discovery at the preclinical level to a much wider audience of patient-related doctors and clinicians; not many conferences are able to bridge this gap.

Celerino Abad-Zapatero, Ph.D.

University of Illinois at Chicago

I wish to thank you for the opportunity you gave to me to present in your congress in Vienna in 2021 our new approach of the melanoma problem. Also the active participation of the audience was not just a common one. In between I hope that until your next congress this year we will have more new results to present.
To have an idea is the first step, but to arrive even to results is the ultimate step.

Konstantin Zioutas

University of Patras

It has been a very complete congress covering all areas of knowledge. My experience was very satisfactory, I received the necessary help from the organization and the virtual presentation was excellent.

Carlos Morales

Hospital Universitario Central de Asturias

Related to the past ESMED 2021 congress in Viena my experience was good. Both, the Organization and Congress were of high quality. However, in my case, the problem was that only few attendants were during my talk, maybe as a consequence of having two rooms functioning at the same time that could be merged.

Diego Caicedo Valdés, MD, PhD.

Universitario de Santiago de Compostela

November 11-13, 2021

Vienna, Austria + Online

The ESMED Congress is a congress like no other: cutting-edge research, world-renowned speakers, and the opportunity to connect with colleagues from across the globe. Our goal is to deliver an exceptional scientific program which inspires and challenges medical professionals to reach their next great discovery.

We invite you to submit your work and reserve your place by registering early for an unforgettable experience.

Call for Science

Nowhere else will your science have such a significant impact on a global stage. By being a part of the ESMED Congress Program your work will be exposed to the international medical community in a modern learning environment. 

Global recognition for your work

High visibility & impact

Presentation Types

Keynote presentation

25-40 minutes

Session presentation

20-30 minutes

Poster presentation

5-15 Minutes

Online presentation

20-35 Minutes

Feedback from ESMED Congress 2021

The ESMED General Assembly (2022) allowed me to present my work on new optimization methods in drug discovery at the preclinical level to a much wider audience of patient-related doctors and clinicians; not many conferences are able to bridge this gap.

Celerino Abad-Zapatero, Ph.D.

University of Illinois at Chicago

I wish to thank you for the opportunity you gave to me to present in your congress in Vienna in 2021 our new approach of the melanoma problem. Also the active participation of the audience was not just a common one. In between I hope that until your next congress this year we will have more new results to present.
To have an idea is the first step, but to arrive even to results is the ultimate step.

Konstantin Zioutas

University of Patras

Related to the past ESMED 2021 congress in Viena my experience was good. Both, the Organization and Congress were of high quality. However, in my case, the problem was that only few attendants were during my talk, maybe as a consequence of having two rooms functioning at the same time that could be merged.

Diego Caicedo Valdés, MD, PhD.

Universitario de Santiago de Compostela

Important Deadlines

12 March 2021

Early abstract submission deadline

2 April 2021

Early registration savings

1 August 2021

Final abstract submission deadline

ESMED Congress 2021 Program

We are working relentlessly to assemble a scientific program which will showcase the latest knowledge in an interactive and modern platform. 

View PDF Program

This year’s spotlight: Global Public Health

The Coronavirus pandemic has moved public health into the spotlight on an unprecedented scale. Preventing disease requires organized efforts and evidence-based policy options. Analyzing the threats to the health of a population is a difficult challenge which needs multidisciplinary input and careful consideration of the facts. At ESMED Congress 2021 leading public health experts will talk about how we can reduce the global burden of disease and prevent the next pandemic. 

Chaired by Virginia Lynch, Academy of Forensic Nursing

Trends in Oncology

Cancer is the second leading cause of death globally, and is responsible for approximately 10 million deaths annually. ESMED hopes to reduce the burden of cancer by helping to shape healthcare policy in three key areas: Prevention strategies, Early detection, and Treatment.

Chaired by Borje S. Andersson, M.D., Ph.D., MD Anderson Cancer Center

A New Era for Neuroscience

New discoveries within the Neuroscience field are constantly shaping our understanding of the brain and the nervous system. ESMED Congress 2021 will have an emphasis on the following Neuroscience topics: Alzheimers, Epilepsy, Glioblastoma, and Neuronanotechnology.

Chaired by Valery Shestopalov, Ph.D., University of Miami

Exploring Genetics & Genomics

helix

During the last decade there have been enormous advancements in the field of Genetics which have widespread implications across virtually all diseases. Genome editing has the ability to revolutionize medicine, but also poses many challenges. ESMED Congress 2021 will explore the latest innovations in genetics and genomics, with the goal of encouraging a multidisciplinary approach to genetics research.

Chaired by Douglas Andres, Ph.D., University of Kentucky

Advancements in Cardiology

Cardiovascular disease causes 3.9 million deaths in Europe each year. Risk factors such as obesity and diabetes have increased in recent years, resulting in the need for new approaches to reducing the burden of cardiovascular disease. ESMED Congress 2021 aims to advance cardiovascular knowledge in three key areas: Prevention strategies, Early detection, and Treatment.

Chaired by Valery Shestopalov, University of Miami

Advancing Knowledge in Diabetes

The prevalence of Diabetes in Europe has grown to an alarming 10% of adults. Breakthroughs in Diabetes care are urgently needed. ESMED Congress 2021 will examine the latest technologies and ideas for Diabetes care.

Chaired by Philippe Valet, Ph.D., INSERM

Nutrition & Food Science

The fields of Nutrition and Food Science experience rapid change as new technologies become available. ESMED Congress 2021 aims to advance nutrition knowledge be exploring the latest innovation in the field.Chaired by Matthew Moore, University of Massachusetts

Pharmacology Trends

Spotlight on Surgery

Nutrition & Food Science

Focus on Neonatology

Medical Nanotechnology

The Future of Psychology

Breakthroughs in Pediatrics

Nursing/Healthcare Management

Trends in Endocrinology

Next Generation Immunology

Focus on Pulmonology

Advancements in Physiology

Hilton Vienna Danube Waterfront Hotel

Featured Keynote Speakers

Terrence Murphy

Yale School of Medicine

Integration of Fall Prevention into State Policy in Connecticut

Dr. Murphy is a member of the biostatistics staff of the Program on Aging. With twelve years experience in the design and manufacture of clinical instrumentation and advanced training in engineering statistics, he is interested in the application of engineering tools to research on aging. Current areas of investigation include multivariate statistics for characterization of multiple co–morbidity, robust design techniques for assessing the tradeoffs of multiple medication use, and the use of hierarchical models, propensity scores, and Bayesian techniques to enhance the analysis of non-randomized interventional designs such as the fall–related utilization of healthcare services by older persons in the state of Connecticut.

Helen Noble

Queen’s University Belfast

Mindfulness Based Interventions for people for kidney disease

Dr Helen Noble’s research is focused on two areas; (i) improving the quality of life of people with end-stage kidney disease (and their carers) from diagnosis through to end of life. 

Joan-Lluis Vives-Corrons

University of Barcelona

Diagnostic approach of hereditary red blood cell membranopathies: From Osmotic Gradient Ektacytometry (OGE) to Next Generation Sequencing (NGS)

Joan-Lluis Vives Corrons is a Professor of Medicine (1976-present) and Head of the Red Blood Cell Pathology Unit (1997 –present) at the Hospital Clínic i Provincial (University of Barcelona), with main activity focused on the diagnosis of RBC defects and in the identification of low prevalence anaemias or “Rare Anaemias”.Research has mainly based on physiopathology, molecular mechanisms and epidemiology of red blood cell (RBC) disorders due to hereditary enzymopathies (G6PD, PK and others), haemoglobinopathies (Sickle-cell anaemia and thalassaemias) and membrane defects.

Jan Ilhan Kizilhan

Institute for Transcultural Health Science, Germany

Transcultural Aspects of Psychotraumatology in Medicine

Jan Ilhan Kizilhan is a psychologist, author and publisher, with research interests in psychotraumatology, sexual violation, trauma, terror and war, transcultural psychiatry, psychotherapy, clinical psychology and psychotherapy, migration research and socialization-war research.

Andrea Kleindienst

Dept. of Neurosurgery Univ. Erlangen-Nürnberg

Therapeutic Enhancement of Adult Neurogenesis following Brain Injury

Dr. Andrea Kleindienst was born and raised in Berlin, where she studied medicine at the Free University Berlin and earned her doctorate. She is a German board-certified neurosurgeon since 1998 and has an accreditation by the United States Educational Commission for Foreign Medical Graduates in 2003. Dr. Kleindienst completed graduation in X-Ray and computed tomography diagnostics, emergency and intensive care medicine, manual medicine/ chiropractic therapy, acupuncture, and psychosomatic medicine. 

Jan Verbruggen

Maastricht University Medical Center

Pre-operative cardiac evaluation of patients with a hip fracture, still sensible?

Dr. Verbruggen studied medicine at the Catholic University of Leuven. After obtaining his medical degree, he was trained as a surgeon in the University Hospitals of the University of Leuven and the hospitals affiliated with it. In 1993 he was recognized as a General Surgeon, after which he further specialized in trauma surgery at the Klinikum in Garmisch-Partenkirchen, Germany and subsequently at the Maastricht UMC + (then Academic Hospital Maastricht). He worked for a year as Oberarzt at the Unfall Surgery department of the Klinikum in Aachen and returned to Maastricht UMC + in 1999 as a staff member for Surgery with a focus on Trauma Surgery.

Thomas F. Lüscher

Royal Brompton & Harefield Hospitals/Imperial College

Inflammation and Acute Coronary Syndromes

Professor Thomas F. Lüscher is the Director of Research, Education & Development and Consultant of Cardiology at Royal Brompton & Harefield Hospital Trust and Imperial College in London and Director of the Center for Molecular Cardiology at the University Zurich (Campus Schlieren).

From 1996 – 2017 he was Chairman of Cardiology at the University Hospital Zurich and Director of the Center for Molecular Cardiology at the University Zurich (Campus Schlieren, Wagi-Areal), Switzerland.

Jolien Gooijers

KU Leuven, Belgium

Advanced neuroimaging in relation to motor control post traumatic brain injury

The nearest airport is Vienna International Airport (VIE)

Hilton Vienna Danube Waterfront Hotel

Step 1


Step 2

Payment

Basic

$ 369
  • Access to all sessions

Basic + Membership

$ 899
  • 1 Year ESMED membership
  • Access to all sessions

VIP

$ 1,099
  • Full-text publication *
  • 2 Year ESMED membership
  • Presentation preparation assistance
  • Access to all sessions

* Publication of one manuscript in the Medical Research Archives, the official open-access journal of the European Society of Medicine.